Edition:
United States

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

63.36EUR
11:35am EST
Change (% chg)

€-1.04 (-1.61%)
Prev Close
€64.40
Open
€64.00
Day's High
€64.45
Day's Low
€62.99
Volume
3,476,697
Avg. Vol
4,150,684
52-wk High
€108.47
52-wk Low
€60.27

Chart for

About

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and... (more)

Overall

Beta: 0.98
Market Cap(Mil.): €96,918.28
Shares Outstanding(Mil.): 826.95
Dividend: 2.70
Yield (%): 2.30

Financials

  BAYGn.DE Industry Sector
P/E (TTM): 22.18 31.13 34.39
EPS (TTM): 5.29 -- --
ROI: 8.69 15.55 14.96
ROE: 16.39 16.92 16.52

UPDATE 2-Thyssenkrupp fills key management posts after year of turmoil

* Walker appointed CEO of Thyssenkrupp's elevator unit (Recasts, adds elevator CEO appointment, details)

5:24am EST

Thyssenkrupp proposes former Bayer finance chief as CFO

FRANKFURT, Dec 14 Thyssenkrupp on Friday said it would propose to appoint former Bayer finance chief Johannes Dietsch as chief financial officer, continuing to fill numerous vacant jobs that have been left unfilled following months of crisis.

2:50am EST

Bayer CEO says has not had contact with activist investor Elliott

DUESSELDORF Bayer Chief Executive Werner Baumann said on Monday he has not had any contact with Elliott Management, following a Reuters report which said the U.S.-based activist investor had taken a position in the German pharmaceuticals giant.

Dec 10 2018

Deals of the day-Mergers and acquisitions

Dec 7 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Friday:

Dec 07 2018

Exclusive: Activist investor Elliott has stake in Germany's Bayer - sources

FRANKFURT/NEW YORK Activist investor Elliott has taken a position in Germany's Bayer , adding to the slew of investments the fund has made in German companies, three people familiar with the matter told Reuters on Friday.

Dec 07 2018

Activist investor Elliott has taken position in Germany's Bayer -sources

FRANKFURT/NEW YORK, Dec 7 Activist investor Elliott has taken a position in Germany's Bayer, the latest in a string of investments in German companies, three people familiar with the matter told Reuters on Friday.

Dec 07 2018

Bayer's German workers mostly spared from Monsanto-related job cuts: labor boss

Leverkusen (Germany) The lion's share of job cuts from folding U.S. seed maker Monsanto into Bayer's agriculture unit will affect workers outside Germany, the head of Bayer's works council told Reuters.

Dec 07 2018

Bayer's German workers mostly spared from Monsanto-related job cuts - labour boss

* Largest part of cuts from integration will be abroad-labour rep

Dec 07 2018

German stocks - Factors to watch on Dec. 7

BERLIN, Dec 7 The following are some of the factors that may move German stocks on Friday:

Dec 07 2018

Lower drug sales potential at Bayer underscores need for deals

FRANKFURT Germany's Bayer , which acquired seed company Monsanto this year, reduced its combined sales estimate for its most promising experimental drugs, acknowledging it needs to do more to replenish the development pipeline.

Dec 05 2018

Earnings vs. Estimates